| Filed On | Filing |
|---|---|
| 09 Oct 2026 |
Form 4: Clark Kevin P, Director
Sold 49,517 shares ($2.23M) · Sold 47,761 shares ($2.12M) |
| 22 Sep 2026 |
Form 4: Alving Amy E, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Clark Kevin P, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Vinci Sharon, Chief People Officer
Granted 172.634 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Celian Jason, Chief Accounting Officer
Granted 25.753 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Ostermann Douglas R, Chief Financial Officer
Granted 480.603 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Liotine Joseph T., Director
Granted 489.229 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Cerepak Brad M, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Kueppers Eric, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Tamez Armando, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Meister Paul M, Director
Granted 14.65 Dividend Equivalent Rights |
| 22 Sep 2026 |
Form 4: Acosta Janis N, CLO and Secretary
Granted 113.023 Dividend Equivalent Rights |
| 10 Sep 2026 |
Form 4: Clark Kevin P, Director
Sold 48,592 shares ($2.33M) · Sold 74,130 shares ($3.39M) |
| 08 Sep 2026 | 144 |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 31 Jul 2026 | SCHEDULE 13G |
| 31 Jul 2026 | SCHEDULE 13G |
| 30 Jul 2026 | SCHEDULE 13G/A |
| 23 Jun 2026 |
Form 4: Liotine Joseph T., Director
Gave up 21,289 shares to cover exercise price or tax ($977K) |
Loading...